Arrhythmias & electrophysiology

Cryptogenic stroke in women: impact of insertable cardiac monitoring in the STROKEWISE cohort study

EuropacePublished Cohort study

Main finding · AF detectionResult — go to the resultOdds ratio 6.9 95% CI 3.7–13.5

Authors' conclusion

ICM increased AF detection and enabled safe anticoagulation in women with acute cryptogenic stroke. Although stroke recurrence did not differ significantly, signals of lower mortality and major bleeding support prolonged monitoring to optimize secondary prevention.

Study context

Population
Women with cryptogenic stroke, Norwegian Stroke Registry, 2016–23
Participants
475 women
Exposure
Insertable cardiac monitoring (ICM) vs standard non-invasive follow-up
  • ICMn = 262
Outcome
Atrial fibrillation (AF) detection and recurrent stroke
Follow-up
1 and 2 years
Methodological detailstwo-centre, registry-based, multivariable-adjusted
  • Two-centre
  • Registry-based
  • Multivariable-adjusted

Main finding

AF detection

Odds ratio

6.9

95% CI 3.7–13.5

P < 0.001

By group

ICM vs Control
OR 6.9 (95% CI 3.7–13.5); P < 0.001

As reported in the abstract

No significant difference in recurrent stroke (HR 1.8, 95% CI 0.78-4.36)
P = 0.17

Observational data: associations, not effects.

Secondary outcomes

OutcomeOR (95% CI)P value
2-year mortality (fixed-time analysis)0.40 (0.16–0.94)P = 0.036

Mortality · median follow-up 42 months

No significant difference in mortality (HR 0.88, 95% CI 0.58-1.58)
P = 0.88

Composite stroke and mortality · median follow-up 42 months

No significant difference in the composite outcome (HR 0.96, 95% CI 0.6-1.5)
P = 0.85

Safety

OutcomeOR (95% CI)P value
Bleeding events (fixed-time analysis)Fewer with ICM0.19 (0.06–0.52)P = 0.002

Original publication

Cryptogenic stroke in women: impact of insertable cardiac monitoring in the STROKEWISE cohort study. Europace. Published 23 March 2026. doi:10.1093/europace/euag056

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.